Clinical Trials in Atlanta

Showing 17541-17560 of 19,805 trials

Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients

NCT00379418

AIR STUDY TITLE: Anti-Ischemic effects of Abciximab(Reopro) PATIENT POPULATION: Patients undergoing PCI(an interventional procedure placing a small stent/metallic tube to keep a narrowed artery in your heart open) and either on a stable statin dose or not on a statin. Statin= cholesterol lowering drug(ie, lipitor, zocor). INTERVENTION: Heparin vs. heparin + abciximab during PCI PURPOSE: Measure the effects of abciximab on special healing blood stem cells (EPC's-Endothelial Progenitor Cells), on inflammation, on oxidative stress and on microvascular blood flow. PATIENT ASSESSMENT: 1. 50ccs blood draw on day 1(from sheath), day 2 ,day 7 and day 28. 2. Measurement of blood flow in selected suitable patients 3. 10 minute questionnaire before discharge and on visit on day 28.

Coronary Artery Disease

Emory University220 participantsStarted Jan 2003

Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDPhase 4< 1 mile

RESTART C0168Z05 Rheumatoid Arthritis Study

NCT00714493

The purpose of this study is to assess the effectiveness of treatment in patients with active rheumatoid arthritis who are having an inadequate response to at least 3 months of treatment with etanercept or adalimumab in addition to methotrexate.

Rheumatoid Arthritis

Centocor Ortho Biotech Services, L.L.C.203 participantsStarted Jul 2008

Huntsville, Alabama, United States • Paradise Valley, Arizona, United States • Tucson, Arizona, United States +73 more locations

Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients

RESTART C0168Z05 Rheumatoid Arthritis Study

Find Trials by Condition in Atlanta

Dopamine in Acute Decompensated Heart Failure II

Psychoeducational Intervention for ICD Patients (PEACE)

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

RNS® System Pivotal Study

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Intervention to Retain HIV-positive Patients in Medical Care

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Ultrasound Elastography of Breast Lesions

Comparison of SureCALL® Labor Monitor® and Tocodynamometer Measurement in Preterm and Term Pregnant Women